Egil Støre Blix
Lars,
Lars Andreas,
Egil Støre,
Beate,
Elin Faye,
Marianne B.
et al.:
Cost-Effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector - and Societal Perspectives
Dagny,
Thomas Karsten,
Mona Irene,
Egil Støre,
Ilona Halva,
Erna-Elise
et al.:
High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC
Hege Oma,
Egil Støre,
Lars Andreas,
Bjørnar,
Sunil Xavier,
Helle
et al.:
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1)
Katarina,
Gro Live,
Sigmund,
Pitt,
Egil Støre,
Eli Sihn Samdal
et al.:
IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results
Jürgen,
Peeter,
Malgorzata,
Antonis,
Cecilia,
Cathrine Bergquist
et al.:
Current treatment landscape of HR+/HER2− advanced breast cancer in the Nordics: a modified Delphi study
Oleksii,
Hans Petter,
Elisabet Ognedal,
Bjørnar,
Steinar,
Egil Støre
et al.:
Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development
Synnøve,
Christina,
A.,
Oleksii,
Olav Karsten,
Reidun Kristine
et al.:
Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer
Albulena,
Geeta,
Siri Lagethon,
Espen,
Morten Wang,
Alf Inge
et al.:
Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial
Thomas,
Bjørn,
Steinar,
Ersilia,
Jan Terje,
Anna Barbro
et al.:
Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
Hans Petter,
Synnøve,
Asmaa,
Alba,
Bjørnar,
Egil Støre
et al.:
Olaparib monotherapy as primary treatment in unselected triple negative breast cancer
Lars,
Line,
Sajitha,
Liv Hege,
Hans Petter,
Egil Støre
et al.:
Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer
Acta Oncologica 2019 DOI
Sigurd,
Mehrdad,
Inigo Zubiavrre,
Elin,
Samer,
Erna Elise
et al.:
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
Clinical Lung Cancer 2018 DOI
Giulio,
Mette S.,
Esben S.,
Carine,
Ingelise,
Egil Støre
et al.:
Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1
Radiotherapy and Oncology 2017 DOI
Ahmed R.,
Giulio,
Mette S.,
Esben S.,
Tine B.,
Carine
et al.:
Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional study
Clinical and Translational Radiation Oncology 2017 DOI
AR,
ES,
TB,
MS,
HM,
P
et al.:
Internal and external validation of an ESTRO delineation guideline - dependent automated segmentation tool for loco-regional radiation therapy of early breast cancer.
Radiotherapy and Oncology 2016 DOI
Kari,
Egil Støre,
Anne,
Anders,
Andreas Tendeland,
Tom
et al.:
A longitudinal study of maternal endothelial function, inflammatory response and uterine artery blood flow during the second half of pregnancy
Acta Obstetricia et Gynecologica Scandinavica 2016 DOI
Egil Støre,
Anne
:
Raiders of the lost mark – endothelial cells and their role in transplantation for hematologic malignancies
Leukemia and Lymphoma 2016 DOI
Egil Støre,
Anders Benjamin,
Eirin Listau,
Anders,
June,
Arne
et al.:
Content of endothelial progenitor cells in autologous stem cellgrafts predict survival after transplantation for multiplemyeloma
Egil Støre,
Jonathan M.,
Anne,
Jan,
Lise,
Anne
et al.:
Phospho-spesific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
Ingrid,
Gro Live,
Tonje,
Vigdis,
Laxmi,
J Christopher
et al.:
Comprehensive genomic profiling of circulating tumor DNA for treatment recommendation: A sub-project of the IMPRESS-Norway trial.
2024
Åslaug,
Eli Sihn Samdal,
Egil Støre,
Åsmund,
Sigmund,
Katarina
et al.:
Hever kvaliteten på behandling av kreft
Cecilie Fredvik,
Kristina Yvonne Kathe,
Katharina,
Guro,
Ingvild,
Vibeke Anett
et al.:
456 Molecular characteristics of gynaecological cancer patients in the IMPRESS-Norway trial – a national prospective, non-randomized clinical trial evaluating the efficacy of anti-cancer drugs on new indications
Camilla Øvrebø,
Åslaug,
Egil Støre,
Daniel,
Kristina Yvonne Kathe
:
ESMO-kongressen 2023 – dette gleder kreftlegene seg til
20. Oktober 2023
Kjetil,
Hege Elisabeth Giercksky,
Eline,
Line,
Egil Støre,
Terje C.
et al.:
A national precision cancer medicine implementation initiative for Norway
Åslaug,
Hege Elisabeth Giercksky,
Gro Live,
Khalid Ibrahim,
Yvonne,
Thomas
et al.:
Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway (Journal of Translational Medicine, (2022), 20, 1, (225), 10.1186/s12967-022-03432-5)
Journal of Translational Medicine 2022 DOI
Egil Støre
:
A national precision cancer medicine implementation initiative for Norway
Nature Medicine 2022 DOI
Egil Støre
:
Åslaug Helland og Egil Blix, • IMPRESS–Norway - hvordan går det?
2022
Åslaug,
Hege Elisabeth Giercksky,
Gro Live,
Khalid Ibrahim,
Yvonne,
Thomas
et al.:
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
Egil Støre
:
Persontilpasset medisin hos pasienter med brystkreft
2019
Hans Petter,
Synnøve,
Egil Støre,
Steinar,
Geirfinn,
Helge
et al.:
Neoadjuvant olaparib monotherapy in primary triple negative breast cancer
2019
Hans Petter,
Christina,
Egil Støre,
Steinar,
Geirfinn,
Helge
et al.:
Neoadjuvant endocrine therapy with palbociclib in patients with high-risk breast cancer
2019
Mona,
Pål,
Mika,
Egil Støre,
Jouko
:
Authors' reply: Risk factors for obstetric anal sphincter injury after a successful multicentre interventional programme
BJOG: An International Journal of Obstetrics and Gynaecology 2014 DOI
Kari,
Anne,
Åse,
Egil Støre,
Tom,
Ganesh
:
A longitudinal study of maternal vascular reactivity, circulating endothelial progenitor celss and inflammatory response during the second half of pregnancy
Pregnancy Hypertension 2013
Mona,
Jouko,
Egil Støre,
Tom,
Barthold,
Pål
:
ANAL INCONTINENCE AND SEXUAL PROBLEMS IN WOMEN WITH EPISIOTOMY - A MATCHED CASE-CONTROL STUDY
Neurourology and Urodynamics 2012
Mona,
Jouko,
Egil Støre,
Tom,
Barthold,
Pål
:
Epsiotomy characterisitics and risk for anal sphincter injuries: a case-control study
Acta Obstetricia et Gynecologica Scandinavica 2012
Egil Støre,
Jonathan M.,
Anne,
Jan,
Anne,
June
et al.:
Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients
British Journal of Haematology 2012 DOI
Egil Støre,
Anne
:
Endothelial progenitor cells (EPC)-expression and function in cancer
2006
Egil Støre,
Anne
:
Endothelial progenitor cells (EPC)- expression and function in cancer
Regional forskningskonferanse innen medisin og helse 2006
The 50 latest publications is shown on this page. See all publications in Cristin here →